Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lorcaserin Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys
Gregory T. Collins, Lisa R. Gerak, Martin A. Javors, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 356, Iss. 1, pp. 85-95
Open Access | Times Cited: 54

Showing 26-50 of 54 citing articles:

The 5‐HT2C receptor as a therapeutic target for alcohol and methamphetamine use disorders: A pilot study in treatment‐seeking individuals
Erin J. Campbell, Yvonne Bonomo, Adam Pastor, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 18
5HT‐2C agonist lorcaserin decreases cannabis self‐administration in daily cannabis smokers
Caroline A. Arout, Ziva D. Cooper, Stephanie Collins Reed, et al.
Addiction Biology (2021) Vol. 26, Iss. 4
Open Access | Times Cited: 13
Adjunctive effect of the serotonin 5-HT2C receptor agonist lorcaserin on opioid-induced antinociception in mice
Salvador Sierra, Kumiko Lippold, David L. Stevens, et al.
Neuropharmacology (2020) Vol. 167, pp. 107949-107949
Open Access | Times Cited: 14
Characterization of the discriminative stimulus effects of lorcaserin in rats
Katherine M. Serafine, Kenner C. Rice, Charles P. France
Journal of the Experimental Analysis of Behavior (2016) Vol. 106, Iss. 2, pp. 107-116
Open Access | Times Cited: 12
3,4-Methylenedioxypyrovalerone High-Responder Phenotype as a Tool to Evaluate Candidate Medications for Stimulant Use Disorder
Michelle R. Doyle, Lindsey N. Peng, Jianjing Cao, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 384, Iss. 3, pp. 353-362
Open Access | Times Cited: 4
Preference for an Opioid/Benzodiazepine Mixture over an Opioid Alone Using a Concurrent Choice Procedure in Rhesus Monkeys
Peter F. Weed, Charles P. France, Lisa R. Gerak
Journal of Pharmacology and Experimental Therapeutics (2017) Vol. 362, Iss. 1, pp. 59-66
Open Access | Times Cited: 12
Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of Action
Myra Alayoubi, Brittany A. Henry, Catherine M. Cahill, et al.
Drugs (2024) Vol. 84, Iss. 11, pp. 1395-1417
Open Access | Times Cited: 1
Studies To Examine Potential Tolerability Differences between the 5-HT2C Receptor Selective Agonists Lorcaserin and CP-809101
Guy A. Higgins, Leonardo B. Silenieks, Amy Patrick, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 5, pp. 1074-1084
Closed Access | Times Cited: 10
Effects of lorcaserin (Belviq®) on nicotine- and food-maintained responding in non-human primates
David S. Jacobs, Claire Barkin, Michelle R. Kohut, et al.
Drug and Alcohol Dependence (2017) Vol. 181, pp. 94-101
Open Access | Times Cited: 10
Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release
Ryan T. Hurt, Manpreet S. Mundi, Jon O. Ebbert
Diabetes Metabolic Syndrome and Obesity (2018) Vol. Volume 11, pp. 469-478
Open Access | Times Cited: 9
Comparison of the effects of abstinence on MDMA and cocaine self-administration in rats
Quenten Highgate, Susan Schenk
Psychopharmacology (2018) Vol. 235, Iss. 11, pp. 3233-3241
Closed Access | Times Cited: 9
Omega-3 Fatty Acids and Vulnerability to Addiction: Reviewing Preclinical and Clinical Evidence
Valerie L. Darcey, Katherine M. Serafine
Current Pharmaceutical Design (2020) Vol. 26, Iss. 20, pp. 2385-2401
Closed Access | Times Cited: 9
Effects of buprenorphine/lorcaserin mixtures on preference for heroin, cocaine, or saline over food using a concurrent choice procedure in rhesus monkeys
Lisa R. Gerak, Charles P. France
Drug and Alcohol Dependence (2021) Vol. 227, pp. 108991-108991
Open Access | Times Cited: 7
Acute and chronic interactive treatments of serotonin 5HT2C and dopamine D1 receptor systems for decreasing nicotine self-administration in female rats
Blair K. A. Willette, Anica Nangia, Sarah A. Howard, et al.
Pharmacology Biochemistry and Behavior (2019) Vol. 186, pp. 172766-172766
Open Access | Times Cited: 6
Serotonin neurobiology in cocaine use disorder
Kathryn A. Cunningham, Leonard L. Howell, Noelle C. Anastasio
Handbook of behavioral neuroscience (2020), pp. 745-802
Closed Access | Times Cited: 6
Biphasic reward effects are characteristic of both lorcaserin and drugs of abuse: implications for treatment of substance use disorders
Ken W. Grasing, Kim Burnell, Alok De
Behavioural Pharmacology (2022) Vol. 33, Iss. 4, pp. 238-248
Open Access | Times Cited: 4
Results of a randomized, double-blind, placebo-controlled trial of lorcaserin in cocaine use disorder
David J. McCann, Hegang H. Chen, Eric Devine, et al.
Drug and Alcohol Dependence (2023) Vol. 255, pp. 111063-111063
Closed Access | Times Cited: 2
Novel Pharmacological Agents for the Treatment of Cocaine Use Disorder
Hasti Hadizadeh, José M. Flores, Eric J. Nunes, et al.
Current Behavioral Neuroscience Reports (2022) Vol. 9, Iss. 1, pp. 27-46
Closed Access | Times Cited: 3
Evaluation of the 5-HT2C receptor drugs RO 60-0175, WAY 161503 and mirtazepine in a preclinical model of comorbidity of depression and cocaine addiction
Joanna Jastrzębska, Małgorzata Frankowska, Irena Smaga, et al.
Pharmacological Reports (2022) Vol. 75, Iss. 1, pp. 99-118
Open Access | Times Cited: 3
Medication Strategies for the Management of Cocaine Use Disorder
Stephen J. Kohut, Jack Bergman
Elsevier eBooks (2017), pp. 627-637
Closed Access | Times Cited: 3
Medications development for food-based and drug use disorders
Fernando B. de Moura, Stephen J. Kohut, Jack Bergman
Advances in pharmacology (2019), pp. 197-236
Closed Access | Times Cited: 3
The antidepressant agomelatine attenuates morphine-induced reinstatement but not self-administration or precipitated withdrawal
Alok De, Ken W. Grasing
Pharmacology Biochemistry and Behavior (2023) Vol. 223, pp. 173525-173525
Open Access | Times Cited: 1
Effects of access condition on substance use disorder-like phenotypes in male and female rats self-administering MDPV or cocaine
Michelle R. Doyle, Nina M. Beltran, Mark S.A. Bushnell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Effects of access condition on substance use disorder-like phenotypes in male and female rats self-administering MDPV or cocaine
Michelle R. Doyle, Nina M. Beltran, Mark S.A. Bushnell, et al.
Drug and Alcohol Dependence (2024) Vol. 263, pp. 112408-112408
Open Access
The Role of 5-HT2a/2c Receptors in Nociception and Opioid Antinociception: a Review of the Preclinical Literature
Kumiko Lippold, William L. Dewey
Current Treatment Options in Psychiatry (2017) Vol. 4, Iss. 2, pp. 210-220
Closed Access | Times Cited: 2

Scroll to top